5328152026-09-045328152026-09-042026-09-04RelatedPartyTransactionDomain15328152026-09-042026-09-04RelatedPartyTransactionDomain25328152026-09-042026-09-04RelatedPartyTransactionDomain35328152026-09-042026-09-04RelatedPartyTransactionDomain45328152026-09-042026-09-04ResolutionOrAgendaDomain15328152026-09-04ResolutionOrAgendaDomain15328152026-09-042026-09-04ResolutionOrAgendaDomain25328152026-09-04ResolutionOrAgendaDomain25328152026-09-042026-09-04ResolutionOrAgendaDomain35328152026-09-04ResolutionOrAgendaDomain35328152026-09-042026-09-04ResolutionOrAgendaDomain45328152026-09-04ResolutionOrAgendaDomain45328152026-09-042026-09-04ResolutionOrAgendaDomain55328152026-09-04ResolutionOrAgendaDomain55328152026-09-042026-09-04ResolutionOrAgendaDomain65328152026-09-04ResolutionOrAgendaDomain65328152026-09-042026-09-04ResolutionOrAgendaDomain75328152026-09-04ResolutionOrAgendaDomain7iso4217:INRxbrli:pureSMS PHARMACEUTICALS LIMITEDSMSPHARMANew2026-09-0410:30:002026-09-04Annual General MeetingVideo Conference (VC) or Other Audio-Visual Means (OAVM)38TUESDAY2026-09-2910:30:00HYDERABAD7SMS Pharmaceuticals LimitedVKT Pharma Private LimitedAssociate CompanySale of goods or services17000000002026-09-292027-12-28from conclusion of the 38th AGM till the date of the 39th AGM of the Company to be held in the FY 2027SMS Pharmaceuticals LimitedVKT Pharma Private LimitedAssociate CompanyPurchase of goods or services300000002026-09-292027-12-28from conclusion of the 38th AGM till the date of the 39th AGM of the Company to be held in the FY 2027SMS Pharmaceuticals LimitedVKT Pharma Private LimitedAssociate CompanyAny other transactionRent Receivable100000002026-09-292027-12-28from conclusion of the 38th AGM till the date of the 39th AGM of the Company to be held in the FY 2027SMS Pharmaceuticals LimitedVKT Pharma Private LimitedAssociate CompanyAny other transactionother reimbursement100000002026-09-292027-12-28from conclusion of the 38th AGM till the date of the 39th AGM of the Company to be held in the FY 2027Ordinary ResolutionAdoption of Financial StatementsTo receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the Financial Year ended 31st March, 2026 and the Reports of the Board of Directors and the Auditors thereonOrdinary ResolutionIssuance/Corporate ActionDividendTo consider and declare dividend on the Equity Shares of the Company for the Financial Year ended 31st March, 2026Ordinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRetirement by rotationTo consider re-appointment of Dr. Sunkara Venkata Satya Shiva Prasad (DIN: 10404277), who retires by rotation, at this Annual General Meeting and being eligible, offers himself for re-appointmentNon-Executive - Non-Independent DirectorSunkara Venkata Satya Shiva Prasad104042772024-08-122026-09-29Ordinary ResolutionRelated Party TransactionApproval of Material Related Party Trnsaction with VKT Pharma Private LimitedOrdinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRatificationApproval for remuneration payable to the Cost Auditors for the Financial Year 2026-27OthersCost AuditorM/s. Annapragada & Co., (Formerly: M/s. Harshitha Annapragada & Co.)2026-04-012027-03-31Special ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRe-appointmentApproval for re-appointment of Mr. Ramesh Babu Potluri (DIN: 00166381) as Chairman and Managing Director of the Company and fixation of remunerationExecutive DirectorMr. Ramesh Babu Potluri001663812026-10-012031-09-305Special ResolutionOthersOthersSMS Peptides Private Limited, Subsidiary CompanyApproval to provide Loan to SMS Peptides Private Limited, Subsidiary Company